- Home
- FLNT vs MAIA Comparison
FLNT vs MAIA Comparison
Compare FLNT & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNT
- MAIA
- Stock Information
- Founded
- FLNT 2010
- MAIA 2018
- Country
- FLNT United States
- MAIA United States
- Employees
- FLNT N/A
- MAIA N/A
- Industry
- FLNT Advertising
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- FLNT Consumer Discretionary
- MAIA Health Care
- Exchange
- FLNT Nasdaq
- MAIA Nasdaq
- Market Cap
- FLNT 47.1M
- MAIA 52.8M
- IPO Year
- FLNT N/A
- MAIA 2022
- Fundamental
- Price
- FLNT $2.89
- MAIA $2.00
- Analyst Decision
- FLNT Hold
- MAIA
- Analyst Count
- FLNT 1
- MAIA 0
- Target Price
- FLNT $4.00
- MAIA N/A
- AVG Volume (30 Days)
- FLNT 23.5K
- MAIA 346.7K
- Earning Date
- FLNT 02-27-2025
- MAIA 11-12-2024
- Dividend Yield
- FLNT N/A
- MAIA N/A
- EPS Growth
- FLNT N/A
- MAIA N/A
- EPS
- FLNT N/A
- MAIA N/A
- Revenue
- FLNT $261,976,999.00
- MAIA N/A
- Revenue This Year
- FLNT N/A
- MAIA N/A
- Revenue Next Year
- FLNT $6.23
- MAIA N/A
- P/E Ratio
- FLNT N/A
- MAIA N/A
- Revenue Growth
- FLNT N/A
- MAIA N/A
- 52 Week Low
- FLNT $2.31
- MAIA $1.17
- 52 Week High
- FLNT $4.30
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- FLNT 56.94
- MAIA 44.72
- Support Level
- FLNT $2.53
- MAIA $1.97
- Resistance Level
- FLNT $2.91
- MAIA $2.44
- Average True Range (ATR)
- FLNT 0.13
- MAIA 0.20
- MACD
- FLNT 0.04
- MAIA 0.00
- Stochastic Oscillator
- FLNT 86.02
- MAIA 8.33
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers they are seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.